Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Hackman Jeffrey S. exercised options for 1,159 Fennec Pharmaceuticals Inc. shares (Form 4)

Traded Apr 30, 2026 · Filed May 1, 2026

On Apr 30, 2026, Hackman Jeffrey S. (Director, Chief Executive Officer) exercised options for 1,159 Fennec Pharmaceuticals Inc. shares, leaving 61,666 shares. Filed May 1, 2026 (Form 4).

Options exercised
1,159 shares
Holding after
61,666 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 30, 2026Common SharesOption exercise1,15961,666Direct

Source

View original at SEC

Related